Cite
HARVARD Citation
Le Carpentier, E. et al. (2022). Impact of Inflammation on Midazolam Metabolism in Severe COVID‐19 Patients. Clinical pharmacology & therapeutics. 112 (5), pp. 1033-1039. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Le Carpentier, E. et al. (2022). Impact of Inflammation on Midazolam Metabolism in Severe COVID‐19 Patients. Clinical pharmacology & therapeutics. 112 (5), pp. 1033-1039. [Online].